Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint
- PMID: 11014356
- DOI: 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8
Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint
Abstract
Objective: To evaluate the presence of cells of an early mesenchymal lineage, as judged by the expression of bone morphogenetic protein receptors (BMPRs), in the joints of normal individuals and patients with rheumatoid arthritis (RA).
Methods: Synovial fluids, single cell suspensions of cultured fibroblast-like synoviocytes (FLS), and synovial tissues were examined by immunohistology with antibodies to BMPR type IA (BMPRIA), BMPRIB, and BMPRII and then quantified using computerized image analysis. Other antibodies were evaluated by cytofluorography.
Results: In primary cultures of joint effusions from patients with RA and other forms of inflammatory arthritis, there were large adherent cells with the appearance of either fibroblasts or stromal cells that stained with antibodies to mesenchymal elements-CD44, type I collagen, alpha-actin, and vimentin-but not with antibodies to hematopoietic markers. These cells proliferated rapidly, expressed BMPRIA and BMPRII, and soon became the predominant cells in culture. They were retained through multiple passages and persistently displayed surface vascular cell adhesion molecule 1. Immunohistochemical analysis of cultured RA FLS (passages 3, 4, and 6; n = 6) revealed that 11.6% were BMPR-positive, while only 2.0% of osteoarthritis FLS (passage 4; n = 3) were BMPR-positive, and 1 normal synovial culture had no BMPR-positive cells. In all RA synovial membranes examined (n = 9), BMPRI- and BMPRII-expressing cells were identified in the intimal lining and were also scattered in the subintima. These cells constituted approximately 25% and approximately 7% of the cells in each area, respectively. Double immunostaining showed no coexpression of BMPR-positive cells with CD68, CD34, or CD3. Cells expressing BMPR were not seen in any normal synovial samples (n = 4). Strong staining for BMPR was identified on cells at the invasive front of the pannus and at sites of cartilage erosion.
Conclusion: The inflamed RA joint contains BMPR-positive mesenchymal cells. Their origin is still speculative, but since their counterparts in the bone marrow are essential for osteoclastogenesis, support lymphocyte development and maturation, and protect T cells and B cells from programmed cell death, the BMPR-positive cells may be essential elements in the pathogenesis of RA and other inflammatory forms of chronic synovitis.
Similar articles
-
Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.Arthritis Rheum. 2002 Mar;46(3):663-74. doi: 10.1002/art.10114. Arthritis Rheum. 2002. PMID: 11920402
-
Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics.Arthritis Res Ther. 2006;8(6):R165. doi: 10.1186/ar2073. Arthritis Res Ther. 2006. PMID: 17076892 Free PMC article.
-
Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes.Arthritis Rheum. 2000 May;43(5):1115-21. doi: 10.1002/1529-0131(200005)43:5<1115::AID-ANR22>3.0.CO;2-A. Arthritis Rheum. 2000. PMID: 10817566
-
Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.Immunol Rev. 2010 Jan;233(1):256-66. doi: 10.1111/j.0105-2896.2009.00854.x. Immunol Rev. 2010. PMID: 20193004 Review.
-
The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.Best Pract Res Clin Rheumatol. 2006 Oct;20(5):969-81. doi: 10.1016/j.berh.2006.06.005. Best Pract Res Clin Rheumatol. 2006. PMID: 16980218 Review.
Cited by
-
rhBMP-2 modulation of gene expression in infected segmental bone defects.Clin Orthop Relat Res. 2009 Dec;467(12):3096-103. doi: 10.1007/s11999-008-0599-3. Epub 2008 Nov 19. Clin Orthop Relat Res. 2009. PMID: 19018606 Free PMC article.
-
Transient Existence of Circulating Mesenchymal Stem Cells in the Deep Veins in Humans Following Long Bone Intramedullary Reaming.J Clin Med. 2020 Mar 31;9(4):968. doi: 10.3390/jcm9040968. J Clin Med. 2020. PMID: 32244388 Free PMC article.
-
Comparison of mesenchymal stem cells obtained by suspended culture of synovium from patients with rheumatoid arthritis and osteoarthritis.BMC Musculoskelet Disord. 2018 Mar 9;19(1):78. doi: 10.1186/s12891-018-1998-6. BMC Musculoskelet Disord. 2018. PMID: 29523119 Free PMC article.
-
Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.Stem Cell Rev Rep. 2017 Oct;13(5):611-630. doi: 10.1007/s12015-017-9748-y. Stem Cell Rev Rep. 2017. PMID: 28597211
-
Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.Arthritis Res Ther. 2015 Jul 28;17(1):192. doi: 10.1186/s13075-015-0710-6. Arthritis Res Ther. 2015. PMID: 26215036 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous